Anti-Hypertensive Drugs - Cambodia

Cambodia

The Anti-Hypertensive Drugs market in Cambodia is expected to witness a significant growth in revenue, reaching a projected value of US$3.07m in 2024.
It is anticipated that the market will continue to expand at an annual growth rate of 0.32%, resulting in a market volume of US$3.12m by 2029.
In the global context, United States is expected to generate the highest revenue in the Anti-Hypertensive Drugs market, with an estimated value of US$12,290.00m in 2024.
In Cambodia, there is an increasing demand for generic anti-hypertensive drugs due to their affordability and accessibility.

Key regions: Japan, India, Italy, Brazil, South Korea

Market

Region

Region comparison

Currency

Analyst Opinion

The Anti-Hypertensive Drugs market in Cambodia has been steadily growing in recent years.

Customer preferences: Cambodia has a high prevalence of hypertension among its population, with many individuals requiring medication to manage their condition. As a result, there is a strong demand for anti-hypertensive drugs in the country. Additionally, due to the relatively low income levels in Cambodia, there is a preference for affordable generic drugs over more expensive branded options.

Trends in the market: One major trend in the Anti-Hypertensive Drugs market in Cambodia is the increasing availability of generic drugs. This has been driven by the government's efforts to promote the use of generic drugs in the country, as well as the entry of new players into the market. Another trend is the growing use of combination therapies, which involve the use of two or more drugs to manage hypertension.

Local special circumstances: The Cambodian government has implemented a number of policies to increase access to healthcare in the country, including the provision of free or subsidized medication to those in need. This has helped to drive demand for anti-hypertensive drugs, as more individuals are able to afford the medication they require. Additionally, there is a lack of awareness about hypertension and its associated risks among the general population, which has led to a need for education and awareness campaigns.

Underlying macroeconomic factors: The Cambodian economy has been growing rapidly in recent years, driven by strong performance in the garment and tourism sectors. This has led to an increase in disposable income levels among the population, which has in turn driven demand for healthcare services, including anti-hypertensive drugs. Additionally, the government has made significant investments in the healthcare sector, including the construction of new hospitals and clinics, which has helped to improve access to healthcare services in the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.